PlainRecalls
FDA Devices Moderate Class II Terminated

Philips StentBoost Live R2.0 application, when used with the Philips Azurion with software release R2.x

Reported: April 13, 2022 Initiated: February 2, 2022 #Z-0737-2022

Product Description

Philips StentBoost Live R2.0 application, when used with the Philips Azurion with software release R2.x

Reason for Recall

Due to an incorrect configuration setting in the EPX database of StentBoost Live, acquisition does not stop automatically as it should. When the user selects the StentBoost Live protocol on the Philips Azurion system, the following on-screen message is displayed to the user in the Philips StentBoost Live application: "Press the cine pedal until the acquisition stops". However, due to the incorrect configuration of the EPX database, the acquisition does not stop after 40 images, but instead it continues as long as the pedal is pressed.

Details

Recalling Firm
Philips Healthcare
Units Affected
42 Systems
Distribution
US Nationwide distribution.
Location
Andover, MA

Frequently Asked Questions

What product was recalled?
Philips StentBoost Live R2.0 application, when used with the Philips Azurion with software release R2.x. Recalled by Philips Healthcare. Units affected: 42 Systems.
Why was this product recalled?
Due to an incorrect configuration setting in the EPX database of StentBoost Live, acquisition does not stop automatically as it should. When the user selects the StentBoost Live protocol on the Philips Azurion system, the following on-screen message is displayed to the user in the Philips StentBoost Live application: "Press the cine pedal until the acquisition stops". However, due to the incorrect configuration of the EPX database, the acquisition does not stop after 40 images, but instead it continues as long as the pedal is pressed.
Which agency issued this recall?
This recall was issued by the FDA Devices on April 13, 2022. Severity: Moderate. Recall number: Z-0737-2022.